Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1570 of 5804
-
Glowing dye may help surgeons spot hidden cancer cells during sarcoma removal
Knowledge-focused Recruiting nowTumor margin confirmation is important to confirming appropriate disease excision. Current standard of care is to take select margin samples to pathology for intra-operative readings. However, this is expensive, time consuming, and only assesses the margin contained within the sp…
Phase: PHASE2 • Sponsor: Kurt Weiss • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New antibody drug takes aim at Hard-to-Treat lymphoma
Disease control OngoingThis phase 1 study will investigate the safety, tolerability, pharmacokinetic, pharmacodynamic, and clinical activity of AZD0486, a CD19 x CD3 T-cell engaging bispecific antibody, in subjects with B-cell non-Hodgkin lymphoma (B-NHL).
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a Low-Dose blood thinner keep clots away?
Disease control CompletedDesign: U.S.-based, single-center, randomized placebo-controlled trial. Brief Treatment Description: Low-intensity apixaban (2.5mg twice daily) for extended-duration secondary prevention of VTE after initial treatment for provoked VTE. Purpose: To establish the safety and effic…
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Family planning visits could double as HIV prevention for young women
Prevention CompletedThis a prospective, open-label implementation project to catalyze integration of HIV prevention and PrEP care services for adolescent girls and young women in family planning clinics in Kenya.
Phase: PHASE4 • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 26, 2026 13:32 UTC
-
Brain scans reveal early clues to Parkinson's progression
Knowledge-focused OngoingThe purpose of this project is to increase our understanding of the early state and temporal evolution of neuroplastic changes in the cortex and subthalamic nucleus (STN) of people with PD, and the relationship of these changes to the emergence and expression of PD motor and non-…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Tailored talk therapy shows promise for Non-Verbal kids with autism
Symptom relief OngoingThis research study, Personalized, Responsive Intervention Sequences for Minimally Verbal Children with Autism (PRISM), is designed to maximize language outcomes for limited-language preschoolers, thereby lowering the risk of being classified as "minimally verbal" at age 6, by em…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Coffee as medicine? major trial tests caffeine against Alzheimer's
Symptom relief Recruiting nowSporadic Alzheimer's disease is a multifactorial illness arising a major medico-economic stakes for our aging societies. There is currently no curative treatment available. Coffee is a complex beverage with psychostimulant properties whose main effective element, caffeine, has a…
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Could Pre-Surgery radiation make inoperable breast tumors removable?
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of neoadjuvant radiation therapy in improving local-regional control and facilitating surgical conversion in patients with inoperable locally advanced breast cancer after 2-6 courses of neoadjuvant chemotherapy. Thi…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could 'Zombie Cells' be behind long COVID? new study aims to find out
Knowledge-focused OngoingThe purpose of this study is to test if senescent cells and their secretome contribute to Long-Hauler Syndrome and if a clinical trial of senolytic drugs, which selectively eliminate senescent cells, should be initiated.
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Acupuncture needles take on Chemo's nerve damage
Symptom relief CompletedThis three-armed, multicenter, randomized, parallel, sham-controlled clinical trial will conduct in three centers in Taiwan. The investigators will randomly assign 234 eligible patients into three groups, an acupuncture group (n=90), a sham-controlled group (n=90), and a waitlist…
Phase: NA • Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New program aims to boost treatment adherence in black breast cancer survivors
Disease control Recruiting nowThe purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Immunotherapy before chemo: a new hope for Triple-Negative breast cancer?
Disease control TerminatedThis is a randomized, open-label, adaptive, two arm, multicentre, Phase II trial comparing a neoadjuvant chemotherapy with PDL1-inhibition (Atezolizumab) and Atezolizumab two-week window to chemotherapy with PDL1-inhibition (Atezolizumab) and identify biomarkers predicting (early…
Phase: PHASE2 • Sponsor: Palleos Healthcare GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Own stem cells may heal scarred vocal cords and restore voice
Disease control CompletedThe overall aim of the project is to develop a new method for treatment of untreatable severe hoarseness due to vocal fold scarring by local injection of autologous mesenchymal stromal cells (MSC). At present there is no lasting effective treatment for this condition which result…
Phase: PHASE1, PHASE2 • Sponsor: Karolinska University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Brain mapping breakthrough could revolutionize epilepsy surgery
Knowledge-focused Recruiting nowUpon successful completion of this study, the investigators expect the study's contribution to be the development of noninvasive imaging biomarkers to predict IEEG functional dynamics and epilepsy surgical outcomes. Findings from the present study may inform current and new thera…
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo aims to rebuild bone in spinal cord injury patients
Disease control OngoingTreatment for sublesional bone loss (osteoporosis) in persons with chronic, motor-complete spinal cord injury (SCI) has been limited and unsuccessful to date. Romosozumab, a sclerostin antagonist, has potential to increase bone formation (anabolic) and decrease bone resorption (a…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Can these pills help veterans with PTSD finally sleep?
Symptom relief CompletedMany Veterans with posttraumatic stress disorder (PTSD) have trouble sleeping or have frequent nightmares. So far, no medication has been approved for treatment of insomnia in PTSD. The purpose of this research study is to find out if taking medications called trazodone or eszopi…
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy shows promise for tough head and neck cancers
Disease control CompletedThis is a single-arm, non-randomized pilot study to evaluate the efficacy and tolerability of combination quad-shot palliative radiotherapy with immunotherapy for advanced/recurrent/metastatic head and neck cancer.
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Cancer-Fighting virus injected directly into tumors shows promise in early trial
Disease control TerminatedThis is a Phase I/IIa, multicenter, open-label, consecutive cohorts, dose-escalation study of BT-001 with repeated IT administrations alone and in combination with IV infusions of pembrolizumab.
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Eczema cream shows promise for Long-Term use in large trial
Disease control CompletedThis study was a Phase 3, multicenter, open-label extension study of the long-term safety of roflumilast cream 0.15% (completers of studies ARQ-151-311 or ARQ-151-312 aged ≥6 years and ARQ-151-315 rollovers who turned 6 years of age on study) or roflumilast cream 0.05% (ARQ-151-3…
Phase: PHASE3 • Sponsor: Arcutis Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could a simple nerve zap help veterans heal from brain injury and PTSD?
Symptom relief Recruiting nowMild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) are important conditions for the Veterans Administration (VA) that frequently occur together in combat Veterans from the conflicts in Afghanistan and Iraq. In many Veterans these become chronic, raising t…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC